Oral L-dopa treatment of parkinsonism

Acta Med Scand. 1970 Apr;187(4):247-55. doi: 10.1111/j.0954-6820.1970.tb02939.x.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / administration & dosage
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / metabolism
  • Dihydroxyphenylalanine / therapeutic use*
  • Dihydroxyphenylalanine / urine
  • Dopamine / biosynthesis
  • Humans
  • Parkinson Disease / blood
  • Parkinson Disease / drug therapy*
  • Phenylacetates / blood
  • Phenylacetates / cerebrospinal fluid
  • Phenylacetates / urine
  • Physical Therapy Modalities
  • Placebos
  • Tyrosine / blood

Substances

  • Phenylacetates
  • Placebos
  • Tyrosine
  • Dihydroxyphenylalanine
  • Dopamine